Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: Responses to high fat and high cholesterol diets

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Erdely, Aaron ^a   Kepka Lenhart, Diane ^a   Salmen Muniz, Rebecca ^a   Chapman, Rebecca ^a   Hulderman, Tracy ^a   Kashon, Michael ^b   Simeonova, Petia P ^a   Morris Jr , Sidney M ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN E; ARGINASE; ARGININE; CITRULLINE; ISOENZYME; ORNITHINE; CHOLESTEROL;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BIOAVAILABILITY; C57BL 6 MOUSE; CARDIOVASCULAR DISEASE; CHOLESTEROL DIET; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HYPERLIPOPROTEINEMIA TYPE 3; LIPID DIET; LIVER INJURY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WILD TYPE; ANIMAL; ANIMAL FOOD; BLOOD; C57BL MOUSE; CHEMISTRY; DIET; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ALANINE TRANSAMINASE; ANIMAL FEED; ANIMALS; APOLIPOPROTEINS E; ARGINASE; ARGININE; BIOLOGICAL AVAILABILITY; CHOLESTEROL; CITRULLINE; DIET; ISOENZYMES; MALE; MICE; MICE, INBRED C57BL; ORNITHINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78650114495     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015253     Document Type: Article

References (47)

1. Wu G, Morris SM, Jr. (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336(Pt 1): 1-17.
2. Durante W, Johnson FK, Johnson RA (2007) Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 34: 906-911.
3. Morris SM, Jr. (2005) Arginine metabolism in vascular biology and disease. Vasc Med 10 Suppl 1: S83-87.
4. Napoli C, Ignarro LJ (2009) Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 32: 1103-1108.
5. Yang Z, Ming XF (2006) Endothelial arginase: a new target in atherosclerosis. Curr Hypertens Rep 8: 54-59.
6. Preli RB, Klein KP, Herrington DM (2002) Vascular effects of dietary Larginine supplementation. Atherosclerosis 162: 1-15.
7. Mori M, Gotoh T (2000) Regulation of nitric oxide production by arginine metabolic enzymes. Biochem Biophys Res Commun 275: 715-719.
8. Morris SM, Jr., Kepka-Lenhart D, Chen LC (1998) Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am J Physiol 275: E740-747.
9. Wei LH, Jacobs AT, Morris SM, Jr., Ignarro LJ (2000) IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am J Physiol Cell Physiol 279: C248-256.
10. Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, et al. (2003) Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108: 2000-2006.
11. Demougeot C, Prigent-Tessier A, Marie C, Berthelot A (2005) Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats. J Hypertens 23: 971-978.
12. Hein TW, Zhang C, Wang W, Chang CI, Thengchaisri N, et al. (2003) Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. Faseb J 17: 2328-2330.
13. Johnson FK, Johnson RA, Peyton KJ, Durante W (2005) Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension. Am J Physiol Regul Integr Comp Physiol 288: R1057-1062.
14. Santhanam L, Lim HK, Lim HK, Miriel V, Brown T, et al. (2007) Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res 101: 692-702.
15. White AR, Ryoo S, Li D, Champion HC, Steppan J, et al. (2006) Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension 47: 245-251.
16. Zhang C, Hein TW, Wang W, Miller MW, Fossum TW, et al. (2004) Upregulation of vascular arginase in hypertension decreases nitric oxidemediated dilation of coronary arterioles. Hypertension 44: 935-943.
17. Durante W, Liao L, Peyton KJ, Schafer AI (1997) Lysophosphatidylcholine regulates cationic amino acid transport and metabolism in vascular smooth muscle cells. Role in polyamine biosynthesis. J Biol Chem 272: 30154-30159.
18. Durante W, Liao L, Reyna SV, Peyton KJ, Schafer AI (2001) Transforming growth factor-beta(1) stimulates L-arginine transport and metabolism in vascular smooth muscle cells: role in polyamine and collagen synthesis. Circulation 103: 1121-1127.
19. Wei LH, Wu G, Morris SM, Jr., Ignarro LJ (2001) Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation. Proc Natl Acad Sci U S A 98: 9260-9264.
20. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133-140.
21. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA (1987) Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68: 231-240.
22. Getz GS, Reardon CA (2006) Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol 26: 242-249.
23. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, et al. (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294: 81-90.
24. Tang WH, Wang Z, Cho L, Brennan DM, Hazen SL (2009) Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. J Am Coll Cardiol 53: 2061-2067.
25. Desai MS, Mariscalco MM, Tawil A, Vallejo JG, Smith CW (2008) Atherogenic diet-induced hepatitis is partially dependent on murine TLR4. J Leukoc Biol 83: 1336-1344.
26. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ (1993) Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91: 2572-2579.
27. Shockley KR, Witmer D, Burgess-Herbert SL, Paigen B, Churchill GA (2009) Effects of atherogenic diet on hepatic gene expression across mouse strains. Physiol Genomics 39: 172-182.
28. Vergnes L, Phan J, Strauss M, Tafuri S, Reue K (2003) Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J Biol Chem 278: 42774-42784.
29. Tous M, Ferre N, Camps J, Riu F, Joven J (2005) Feeding apolipoprotein Eknockout mice with cholesterol and fat enriched diets may be a model of nonalcoholic steatohepatitis. Mol Cell Biochem 268: 53-58.
30. Zheng S, Hoos L, Cook J, Tetzloff G, Davis H, Jr., et al. (2008) Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice. Eur J Pharmacol 584: 118-124.
31. Morris SM, Jr. (1992) Regulation of enzymes of urea and arginine synthesis. Annu Rev Nutr 12: 81-101.
32. Morris SM, Jr., Moncman CL, Rand KD, Dizikes GJ, Cederbaum SD, et al. (1987) Regulation of mRNA levels for five urea cycle enzymes in rat liver by diet, cyclic AMP, and glucocorticoids. Arch Biochem Biophys 256: 343-353.
33. Schimke RT (1962) Adaptive characteristics of urea cycle enzymes in the rat. J Biol Chem 237: 459-468.
34. Ryoo S, Gupta G, Benjo A, Lim HK, Camara A, et al. (2008) Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res 102: 923-932.
35. Ikemoto M, Tsunekawa S, Tanaka K, Tanaka A, Yamaoka Y, et al. (1998) Liver-type arginase in serum during and after liver transplantation: a novel index in monitoring conditions of the liver graft and its clinical significance. Clin Chim Acta 271: 11-23.
36. Ikemoto M, Tsunekawa S, Toda Y, Totani M (2001) Liver-type arginase is a highly sensitive marker for hepatocellular damage in rats. Clin Chem 47: 946-948.
37. Reid KM, Tsung A, Kaizu T, Jeyabalan G, Ikeda A, et al. (2007) Liver I/R injury is improved by the arginase inhibitor, N(omega)-hydroxy-nor-L-arginine (nor-NOHA). Am J Physiol Gastrointest Liver Physiol 292: G512-517.
38. Roth E, Steininger R, Winkler S, Langle F, Grunberger T, et al. (1994) LArginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Influence on nitric oxide metabolism. Transplantation 57: 665-669.
39. Li Z, Hulderman T, Salmen R, Chapman R, Leonard SS, et al. (2007) Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ Health Perspect 115: 377-382.
40. Zhang SH, Reddick RL, Burkey B, Maeda N (1994) Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J Clin Invest 94: 937-945.
41. Joyce CW, Amar MJ, Lambert G, Vaisman BL, Paigen B, et al. (2002) The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci U S A 99: 407-412.
42. Marathe C, Bradley MN, Hong C, Lopez F, Ruiz de Galarreta CM, et al. (2006) The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages. J Biol Chem 281: 32197-32206.
43. Qureshi AA, Salser WA, Parmar R, Emeson EE (2001) Novel tocotrienols of rice bran inhibit atherosclerotic lesions in C57BL/6 ApoE-deficient mice. J Nutr 131: 2606-2618.
44. Kyung TW, Lee JE, Phan TV, Yu R, Choi HS (2009) Osteoclastogenesis by bone marrow-derived macrophages is enhanced in obese mice. J Nutr 139: 502-506.
45. Erdely A, Kepka-Lenhart D, Clark M, Zeidler-Erdely P, Poljakovic M, et al. (2006) Inhibition of phosphodiesterase 4 amplifies cytokine-dependent induction of arginase in macrophages. Am J Physiol Lung Cell Mol Physiol 290: L534-539.
46. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
47. Shi O, Morris SM, Jr., Zoghbi H, Porter CW, O'Brien WE (2001) Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene. Mol Cell Biol 21: 811-813.